Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • TGF-beta/Smad
    (2)
  • Others
    (1)
Filter
Search Result
Results for "

LSKL, Inhibitor of Thrombospondin TSP-1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
LSKL, Inhibitor of Thrombospondin TSP-1 2TFA
T7676
LSKL, Inhibitor of Thrombospondin TSP-1 2TFA is activation of TGF-β .
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
LSKL, Inhibitor of Thrombospondin (TSP-1)
T64709283609-79-0
LSKL, INhibitor of Thrombospondin (TSP-1) is a TGF-β1 antagonist that inhibits the binding of TSP-1 to LAP and reduces renal interstitial fibrosis and liver fibrosis. LSKL can also inhibit subarachnoid fibrosis, prevent the occurrence of chronic hydrocephalus and improve long-term neurocognitive deficits after subarachnoid hemorrhage by inhibiting TSP-1-mediated TGF-β1 activity.
    7-10 days
    Inquiry
    LSKL TFA
    LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA), H-Leu-Ser-Lys-Leu-NH2 TFA(283609-79-0 TFA), H-Leu-Ser-Lys-Leu-NH2 TFA
    TP21472828433-17-4
    LSKL TFA (H-Leu-Ser-Lys-Leu-NH2 TFA) is a LAP-TGFβ derivative and a TGF-β1 antagonist that can cross the blood-brain barrier, inhibits the binding of TSP-1 to LAP and reduces renal interstitial fibrosis and liver fibrosis, inhibits subarachnoid fibrosis by inhibiting TSP-1-mediated TGF-β1 activity, prevents the occurrence of chronic hydrocephalus and improves long-term neurocognitive deficits after subarachnoid hemorrhage.
    • Inquiry Price
    Size
    QTY